Restoration of miR-7 expression suppresses the growth of Lewis lung cancer cells by modulating epidermal growth factor receptor signaling

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2511-2516

  Li, Jingrong ^a   Zheng, Yijie ^b,c   Sun, Gengyun ^a   Xiong, Shudao ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Columbia University ^*  (United States)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Epidermal Growth factor receptor; MicroRNA; MiR 7; Oncogene; RAF 1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 7; UNCLASSIFIED DRUG; EGFR PROTEIN, MOUSE; MIRN7 MICRORNA, MOUSE; RAF PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LEWIS LUNG CARCINOMA CELL; MORPHOLOGY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE RAF 1; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; LEWIS CARCINOMA; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE, INBRED C57BL; MICRORNAS; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84914701505     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3519     Document Type: Article

References (33)

1. van Kouwenhove M, Kedde M and Agami R: MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 11: 644-656, 2011.
2. Ryan BM, Robles AI and Harris CC: Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402, 2010.
3. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A and Marsh CB: MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105: 19678-19683, 2008.
4. Xu TP, Zhu CH, Zhang J, et al: MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas. Asian Pac J Cancer Prev 14: 7085-7090, 2013.
5. Yang S, Li Y, Gao J, et al: MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 32: 4294-4303, 2013.
6. Hulf T, Sibbritt T, Wiklund ED, et al: Epigenetic-induced repression of microRNA-205 is associated with MEd1 activation and a poorer prognosis in localized prostate cancer. Oncogene 32: 2891-2899, 2013.
7. Zhang Y, Chen X, Lian H, et al: MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R. Oncol Rep 31: 1445-1452, 2014.
8. Zhang N, Li X, Wu CW, et al: microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis. Oncogene 32: 5078-5088, 2013.
9. Fang Y, Xue JL, Shen Q, Chen J and Tian L: MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 55: 1852-1862, 2012.
10. Saydam O, Senol O, Würdinger T, et al: miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res 71: 852-861, 2011.
11. Xiong SD, Yu K, Liu XH, et al: Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int J Cancer 125: 774-782, 2009.
12. Zheng Y, Xiong S, Jiang P, et al: Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic Biol Med 52: 1307-1317, 2012.
13. Qiu ZX, Wang L, Han J, et al: Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer. Cancer Sci 103: 1774-1779, 2012.
14. Mukherjee R, Bartlett JM, Krishna NS, Underwood MA and Edwards J: Raf-1 expression may influence progression to androgen insensitive prostate cancer. Prostate 64: 101-107, 2005.
15. 2+ overload and cell death. J Clin Invest 122: 1222-1232, 2012.
16. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714, 2009.
17. Khoshnaw SM, Green AR, Powe DG and Ellis IO: MicroRNA involvement in the pathogenesis and management of breast cancer. J Clin Pathol 62: 422-428, 2009.
18. Andorfer CA, Necela BM, Thompson EA and Perez EA: MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med 17: 313-319, 2011.
19. Gong C, Yao Y, Wang Y, et al: Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 286: 19127-19137, 2011.
20. Chan LW, Wang FF and Cho WC: Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer. Curr Top Med Chem 12: 920-926, 2012.
21. Kefas B, Godlewski J, Comeau L, et al: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-3572, 2008.
22. Reddy SD, Ohshiro K, Rayala SK and Kumar R: MicroRNA-7, a homeobox d10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 68: 8195-8200, 2008.
23. Xiong S, Zheng Y, Jiang P, et al: PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer. Br J Cancer 110: 353-362, 2014.
24. Xiong S, Zheng Y, Jiang P, Liu R, Liu X and Chu Y: MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci 7: 805-814, 2011.
25. Chou YT, Lin HH, Lien YC, et al: EGFR promotes lung tumori-genesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. Cancer Res 70: 8822-8831, 2010.
26. Navolanic PM, Steelman LS and McCubrey JA: EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol 22: 237-252, 2003.
27. Sonnweber B, Dlaska M, Skvortsov S, Dirnhofer S, Schmid T and Hilbe W: High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC). J Clin Pathol 59: 255-259, 2006.
28. Mukohara T, Kudoh S, Yamauchi S, et al: Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC). Lung Cancer 41: 123-130, 2003.
29. Bozzetti C, Tiseo M, Lagrasta C, et al: Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites. J Thorac Oncol 3: 18-22, 2008.
30. Lee KM, Choi EJ and Kim IA: microRNA-7 increases radiosen-sitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol 101: 171-176, 2011.
31. Kalinowski FC, Giles KM, Candy PA, et al: Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7. PLoS One 7: e47067, 2012.
32. Duex JE, Comeau L, Sorkin A, Purow B and Kefas B: Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7. J Biol Chem 286: 25377-25386, 2011.
33. Webster RJ, Giles KM, Price KJ, Zhang PM, Mattick JS and Leedman PJ: Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J Biol Chem 284: 5731-5741, 2009.